Sarepta Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Sarepta Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Sarepta Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 95.3M shares, a 2.15% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 95.3M +2.01M +2.15% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 94.5M +1.35M +1.45% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 93.7M +5.78M +6.57% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 93.5M +5.77M +6.58% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 93.3M +5.74M +6.56% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 93.1M +5.64M +6.45% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 88M +823K +0.95% Dec 31, 2022 10-K 2024-02-28
Q3 2022 87.8M +7.81M +9.77% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 87.5M +7.7M +9.65% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 87.5M +7.75M +9.72% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 87.1M +7.75M +9.77% Dec 31, 2021 10-K 2023-02-28
Q3 2021 80M +1.17M +1.48% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 79.8M +1.4M +1.78% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 79.7M +1.79M +2.3% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 79.4M +4.19M +5.57% Dec 31, 2020 10-K 2022-03-01
Q3 2020 78.8M +4.28M +5.75% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 78.4M +4.1M +5.52% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 78M +3.82M +5.16% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 75.2M +4.11M +5.79% Dec 31, 2019 10-K 2021-03-01
Q3 2019 74.5M +7.81M +11.7% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 74.3M +7.98M +12% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 74.1M +8.64M +13.2% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 71.1M +6.28M +9.69% Dec 31, 2018 10-K 2020-02-26
Q3 2018 66.7M +2.13M +3.29% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 66.3M +11M +19.9% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 65.5M +10.6M +19.2% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 64.8M +10M +18.3% Dec 31, 2017 10-K 2019-02-28
Q3 2017 64.6M +10.2M +18.8% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 55.3M +7.47M +15.6% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 54.9M +9.17M +20% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 54.8M +9.13M +20% Dec 31, 2016 10-K 2018-03-01
Q3 2016 54.4M +12.4M +29.5% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 47.9M +6.35M +15.3% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 45.8M +4.41M +10.7% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 45.6M +4.32M +10.5% Dec 31, 2015 10-K 2017-02-28
Q3 2015 42M +658K +1.59% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 41.5M +716K +1.76% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 41.4M +3.37M +8.87% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 41.3M +3.56M +9.43% Dec 31, 2014 10-K 2016-02-25
Q3 2014 41.3M +3.77M +10% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 40.8M +8.37M +25.8% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 38M +6.1M +19.1% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 37.8M +6.05M +19.1% Dec 31, 2013 10-K 2015-02-26
Q3 2013 37.5M +13.2M +54.4% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 32.4M +9.81M +43.4% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 31.9M -104M -76.5% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 31.7M +9.08M +40.1% Dec 31, 2012 10-K 2014-03-03
Q3 2012 24.3M -111M -82.1% Sep 30, 2012 10-Q 2012-11-07
Q2 2012 22.6M -113M -83.3% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 136M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 22.6M -89.7M -79.9% Dec 31, 2011 10-K 2013-03-15
Q3 2011 136M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 136M Jun 30, 2011 10-Q 2011-08-08
Q4 2010 112M Dec 31, 2010 10-K 2012-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.